An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients.
James GilleenYakub FarahCate DavisonSarah KerinsLorena ValdearenasTolga UzGez LahuMax TsaiFrank OgrincAvi ReichenbergSteve C WilliamsMitul A MehtaSukhi S ShergillPublished in: Psychopharmacology (2018)
NCT02079844 .